Vaccine Therapy in Treating Patients With Stage IV Melanoma

Completed · Phase 2

Conditions studied: Melanoma (Skin)

In brief

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Vaccine therapy may be effective in treating stage IV melanoma. PURPOSE: Phase II trial to study the effectiveness of vaccine therapy in treating patients who have stage IV melanoma.

Key facts

Study ID

NCT00042783

Run by

SWOG Cancer Research Network

Starts

2002-09-01

Expected to finish

2006-03-01

Last updated by the study team

2013-06-24

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Arizona Cancer Center at University of Arizona Health Sciences Center — Tucson, Arizona, United States
• USC/Norris Comprehensive Cancer Center and Hospital — Los Angeles, California, United States
• Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
• Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
• Veterans Affairs Medical Center - Biloxi — Biloxi, Mississippi, United States
• CCOP - Columbia River Oncology Program — Portland, Oregon, United States
• University of Washington School of Medicine — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.